Chen Jian-feng, Long Gui-fang, Lin Wei-xiong, Chen Ping
Department of Pediatrics, the Second Affiliated Hospital, he First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, 530007 P.R.China.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004 Oct;21(5):498-501.
To investigate the relationship of beta-thalassemia mutations and the single nucleotide polymorphism(SNP) at position -158 of (G)Gamma-globin gene to the altered levels of fetal hemoglobin(Hb F) of beta-thalassemia heterozygotes.
Hb F was quantitated by alkali denaturation; beta-thalassemia mutations were determined by PCR-allelic specific oligonucleotide(PCR-ASO). The SNP at -158 was analyzed by amplification of (G)Gamma gene promoter fragments from the DNA, followed by Xmn I restriction enzyme digestion.
Among 63 cases with beta-thalassemia trait, 15 had Hb F levels above 2% (2.06%-10.44%). Six beta-thalassemia mutations were observed in this study, namely CD41/42(-TTCT), CD17(A-->T), nt28 (A-->G), CD71/72(+A), IVS-II-654(C-->T) and IVS-I-1(G-->T). There was no difference in the incidence of beta-thalassemia heterozygotes of CD41/42, CD17, CD71/72 and IVS-II-654 between 15 cases with Hb F>/=2% and 48 cases with Hb F<2%. Ten (15.9%) heterozygotes of (G)Gamma-158(C-->T)were detected among 63 cases, and 8 of them (53.33%) belonged to the group of Hb F>/=2% while the remaining 2 cases (4.17%) were in the group of Hb F<2%.
beta-thalassemia mutations of CD41/42, CD17, CD71/72, IVS-II-654 had no influence on Hb F levels, but (G)Gamma-158(C-->T) had a strong association with moderately increased Hb F levels in beta-thalassemia heterozygotes in the Guangxi area of China.
探讨β地中海贫血突变及γ珠蛋白基因-158位点单核苷酸多态性(SNP)与β地中海贫血杂合子胎儿血红蛋白(Hb F)水平改变的关系。
采用碱变性法测定Hb F含量;采用聚合酶链反应-等位基因特异性寡核苷酸(PCR-ASO)法检测β地中海贫血突变。通过扩增DNA中γ珠蛋白基因启动子片段,然后用Xmn I限制性内切酶消化来分析-158位点的SNP。
在63例β地中海贫血特征患者中,15例Hb F水平高于2%(2.06%-10.44%)。本研究观察到6种β地中海贫血突变,即CD41/42(-TTCT)、CD17(A→T)、nt28(A→G)、CD71/72(+A)、IVS-II-654(C→T)和IVS-I-1(G→T)。Hb F≥2%的15例患者与Hb F<2%的48例患者之间,CD41/42、CD17、CD71/72和IVS-II-654的β地中海贫血杂合子发生率无差异。63例患者中检测到10例(15.9%)γ-158(C→T)杂合子,其中8例(53.33%)属于Hb F≥2%组,其余2例(4.17%)属于Hb F<2%组。
CD41/42、CD17、CD71/72、IVS-II-654的β地中海贫血突变对Hb F水平无影响,但γ-158(C→T)与中国广西地区β地中海贫血杂合子Hb F水平中度升高密切相关。